Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 92884

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
August 14, 2023
Product types
Drug
Classifications
Class II
Statuses
Ongoing
Recalling firm wording
Inmar Supply Chain Solutions, LLC

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.

D-1104-2023
Recall number
D-1104-2023
Initiated
August 14, 2023
Classification
Class II
Status
Ongoing
Quantity
Unknown

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.

Code information

Miscellaneous

Distribution pattern

Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown.